Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study

This open‐label randomized controlled pilot study aimed to test the study feasibility of bromhexine hydrochloride (BRH) tablets for the treatment of mild or moderate coronavirus disease 2019 (COVID‐19) and to explore its clinical efficacy and safety. Patients with mild or moderate COVID‐19 were rand...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Sci
Asıl Yazarlar: Li, Ting, Sun, Laifang, Zhang, Wenwu, Zheng, Chanfan, Jiang, Chenchen, Chen, Mingjing, Chen, Di, Dai, Zhijuan, Bao, Shihui, Shen, Xian
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://ncbi.nlm.nih.gov/pubmed/32881359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12881
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller